We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long‐term safety and efficacy of methotrexate in patients with palindromic rheumatism.
- Authors
Ma, Kevin Sheng‐Kai; Liu, Chien‐Te; Kao, Wei‐Chiao; Lee, Yung‐Heng
- Abstract
2 Ma KS-K, Wang L-T, Tsai S-Y. Correspondence to: 'Combination of human umbilical cord mesenchymal (stromal) stem cell transplantation with IFN- treatment synergistically improves the clinical outcomes of patients with rheumatoid arthritis. Additionally, neither HCQ nor MTX was the first-line drug for PR; as such, whether the participants used other first-line medications or treatments may be further included in the analysis. We read with great interest the article by Ghassembaglou et al. reporting the long-term outcomes of methotrexate (MTX)-based treatments for palindromic rheumatism (PR) using MTX.[1] We agree with the authors that MTX may be effective to relieve symptoms of PR, and would like to highlight some points.
- Subjects
RHEUMATISM; METHOTREXATE; PORPHYROMONAS gingivalis infections; SJOGREN'S syndrome; JUVENILE idiopathic arthritis
- Publication
International Journal of Rheumatic Diseases, 2022, Vol 25, Issue 12, p1448
- ISSN
1756-1841
- Publication type
Article
- DOI
10.1111/1756-185X.14420